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Table 1. Mortality rates and standardized mortality ratio (SMR) in HIV-infected adults, ANRS CO8 APROCO-COPILOTE and ANRS CO3 
AQUITAINE cohorts, 1997-2005, overall and according to gender, HIV transmission group and co-infection by hepatitis C virus at baseline. 












(95% CI) SMR (95% CI) 
Overall 2435 6.8 (4.1-7.9) 13954 288 2.1 (1.8-2.3) 7.0 (6.2-7.8) 
Men 1864 6.9 (4.1-7.9) 10777 226 2.1 (1.8-2.4) 4.8 (4.2-5.5) 
Women 571 6.5 (3.9-7.8) 3177 62 2.0 (1.5-2.4) 13.0 (10.0-16.7) 
Hepatitis C          
 positive 574 6.4 (3.6-7.8) 3163 99 3.1 (2.5-3.7) 13.9 (11.3-17.0) 
 negative 1434 7.0 (4.4-7.9) 8519 120 1.4 (1.2-1.7) 4.4 (3.6-5.2) 
HIV transmission group          
 injecting drug users 527 6.2 (3.2-7.8) 2849 93 3.3 (2.6-3.9) 16.3 (13.2-20.0) 
 others 1908 6.9 (4.2-7.9) 11104 195 1.8 (1.5-2.0) 5.5 (4.7-6.3) 
HIV: Human Immunodeficiency Virus; CI: confidence interval 
 
Table 2. Mortality rates and standardized mortality ratio (SMR) in HIV-infected adults, ANRS CO8 APROCO-COPILOTE and ANRS CO3 















(95% CI) SMR (95% CI) 
CD4 cell count ≥ 500/mm3 1208 4.5 (2.1-7.0) 5402 37 0.7 (0.5-0.9) 2.5 (1.8-3.5) 
CD4 cell count 350 to 499/mm3 1263 2.0 (1.0-4.0) 3446 40 1.2 (0.8-1.5) 3.5 (2.5-4.8) 
CD4 cell count 200 to 349/mm3 1296 2.0 (0.6-3.9) 3178 56 1.8 (1.3-2.2) 5.6 (4.2-7.2) 
CD4 cell count <200/mm3 1118 0.6 (0.2-2.7) 1928 155 8.0 (6.8-9.3) 30.3 (25.8-35.5) 
HIV: Human Immunodeficiency Virus; CI: confidence interval 
Table 3. Mortality rates and standardized mortality ratio (SMR) in HIV-infected adults, ANRS CO8 APROCO-COPILOTE and ANRS CO3 AQUITAINE cohorts, 
1997-2005, according to cumulated time spent with CD4 cell count ≥ 500 /mm
3








 Total  Patients with CD4 ≥ 500 /mm3 after the time of truncation 















PY  Deaths 
(n) 
Rates 
(/100 PY)  
(95% CI) SMR (95% CI) 
0  2435 13954 288  1208 4.5 (2.1-7.0) 5402 37 0.7 (0.5-0.9) 2.5 (1.8-3.5) 
1  2182 11685 208  1156 4.2 (2.1-6.4) 4817 29 0.6 (0.4-0.8) 2.1 (1.4-3.1) 
2  2065 9561 176  1083 4.0 (2.1-5.6) 4080 26 0.6 (0.4-0.9) 2.2 (1.4-3.2) 
3  1949 7551 141  1031 3.5 (1.8-4.8) 3345 22 0.7 (0.4-0.9) 2.1 (1.3-3.2) 
4  1835 5660 108  967 3.0 (1.5-3.8) 2606 18 0.7 (0.4-1.0) 2.1 (1.3-3.4) 
5  1648 3915 62  864 2.4 (1.4-3.0) 1880 12 0.6 (0.3-1.0) 1.9 (1.0-3.2) 
6  1430 2389 25  763 1.6 (1.0-2.2) 1189 2 0.2 (0.0-0.4) 0.5 (0.1-1.6) 
7  1143 1084 6  610 0.9 (0.5-1.3) 543 1 0.2 (0.0-0.5) 0.5 (0.0-2.6) 
§
truncation: the time period taken into account starts 1, 2, 3,… years after initiation of cART 
HIV: Human Immunodeficiency Virus; cART: combination antiretroviral therapy; CI: confidence interval 
Table 4. Mortality rates and standardized mortality ratio (SMR) in HIV-infected adults, ANRS CO8 APROCO-COPILOTE and ANRS CO3 

























(/100 PY)  
(95% CI) SMR (95% CI) 
0  2435 13954 288  1263 2.0 (1.0-4.0) 3446 40 1.2 (0.8-1.5) 3.5 (2.5-4.8) 
1  2182 11685 208  1036 2.5 (1.4-4.0) 2960 35 1.2 (0.8-1.6) 3.4 (2.4-4.8) 
2  2065 9561 176  915 2.2 (1.4-3.7) 2434 29 1.2 (0.8-1.6) 3.3 (2.2-4.7) 
3  1949 7551 141  816 2.0 (1.1-3.4) 1925 26 1.4 (0.8-1.9) 3.6 (2.3-5.2) 
4  1835 5660 108  705 1.9 (1.0-3.0) 1430 20 1.4 (0.8-2.0) 3.5 (2.2-5.5) 
5  1648 3915 62  557 1.7 (0.8-2.7) 971 10 1.0 (0.4-1.7) 2.5 (1.2-4.6) 
6  1430 2389 25  410 1.5 (0.7-2.0) 572 5 0.9 (0.1-1.6) 2.0 (0.7-4.8) 
7  1143 1084 6  286 0.8 (0.5-1.3) 257 2 0.8 (0.0-1.9) 1.9 (0.2-6.7) 
§
truncation: the time period taken into account starts 1, 2, 3,… years after initiation of cART 
HIV: Human Immunodeficiency Virus; cART: combination antiretroviral therapy; CI: confidence interval 
